February 15, 2024
1 min watch
Save
VIDEO: Role of circulating tumor DNA in guiding therapeutic choices for colon cancer emphasized
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Rachna T. Shroff, MD, MS, discusses data from the CIRCULATE and COBRA studies, which evaluated the role of circulating tumor DNA in guiding treatment decisions for patients with colon cancer.
Shroff, of University of Arizona Cancer Center, highlighted these studies presented at ASCO Gastrointestinal Cancers Symposium.
"Each of these potentially practice-changing studies demonstrates that we are clearly advancing the needle and moving things forward in terms of integrating novel technologies, novel therapies and novel multidisciplinary techniques in terms of bringing about the best outcomes for our patients," Shroff said.
References:
- Morris VK, et al. Abstract 5. Presented at: ASCO Gastrointestinal Cancers Symposium; Jan. 18-20, 2024; San Francisco.
- Yukami H, et al. Abstract 6. Presented at: ASCO Gastrointestinal Cancers Symposium; Jan. 18-20, 2024; San Francisco.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Shroff reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.